Table 3. Comparison of patient characteristics with and without AF recurrence in non-paroxysmal AF group.
| No recurrence n = 116 | AF recurrence n = 55 | P | |
|---|---|---|---|
| Male, n (%) | 82 (70.7) | 36 (65.5) | 0.489 |
| Age, years old | 58.1 ± 9.1 | 59.3 ± 10.2 | 0.460 |
| History of AF, months | 34.7 ± 27.5 | 46.4 ± 27.6 | 0.010 |
| LAD, mm | 43.1 ± 4.9 | 45.1 ± 5.5 | 0.015 |
| LVEF, % | 61.3 ± 6.7 | 61.4 ± 6.9 | 0.962 |
| Hypertension, n (%) | 61 (52.6) | 25 (45.5) | 0.384 |
| Coronary heart disease, n (%) | 2 (1.7) | 2 (3.6) | 0.817 |
| Rheumatic heart disease, n (%) | 2 (1.7) | 2 (3.6) | 0.817 |
| Cerebral embolism, n (%) | 3 (2.6) | 2 (3.6) | 1.000 |
| Diabetes, n (%) | 15 (12.9) | 10 (18.2) | 0.364 |
| Smoking, n (%) | 25 (21.6) | 7 (12.7) | 0.167 |
| Alcohol, n (%) | 16 (13.8) | 6 (10.9) | 0.599 |
| Amiodarone use, n (%) | 27 (23.3) | 14 (25.5) | 0.755 |
| BB use, n (%) | 38 (32.8) | 19 (34.5) | 0.817 |
| CCB use, n (%) | 14 (12.1) | 6 (10.9) | 0.826 |
| ACEI/ARB use, n (%) | 41 (35.3) | 18 (32.7) | 0.737 |
| Linear ablations, n (%) | 103 (88.8) | 51 (92.7) | 0.422 |
| CFAEs ablations, n (%) | 65 (56.0) | 33 (60.0) | 0.624 |
| Cardioversion during ablation, n (%) | 58 (50.0) | 33 (60.0) | 0.221 |
Note: AF: atrial fibrillation; LAD: left atrial diameter; LVEF: left ventricular ejection fraction; BB: beta-receptor blocker; CCB: calcium channel blocker; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker. CFAEs: complex fractionated atrial electrograms.